Hollister Biosciences Inc. Announces an Increase in Private Placement to $6.5 Million Psychedelics Investing
MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD Psychedelics Investing
Canbud Advances Blockchain for Genetic and Consumer Feedback Information Management Agriculture Investing
Awakn Life Sciences Appoints CRO to Conduct Phase II Study of MDMA as a Treatment for Alcohol Use Disorder Psychedelics Investing
Seelos Therapeutics Announces Dosing of the First Patients in a Study of SLS-002 for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder Psychedelics Investing
Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectometer Cannabis Investing News
